ALB and type 1 diabetes mellitus: The Renin-Angiotensin System Study [36], which evaluated 94 enalapril and 96 losartan users with type 1 diabetes for five years, reported that enalapril users had a non-significantly lower change in glomerular mesangial fraction volume (0.005 ± 0.050 units) and urinary albumin excretion rate (7.7±15.5 μg/min) compared with losartan users (0.026 ± 0.054 units; 10.6 ± 17.6 μg/min).